This analysis was completed To judge the opportunity with the CPPs with tumor-targeting properties to provide a cytotoxic payload to HCC cells. We explored utilizing a CXCR4-targeting peptide, T22, fused with cytotoxic peptide PE24, for a novel therapeutic method for CXCR4+ HCC cells. T22 was picked as the nanocarrier on https://https-1433123-com30853.thelateblog.com/32079827/fascination-about-https-1433966-com